Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota

PLoS Biology

Volumn 5, Issue 10, 2007, Pages 2177-2189

  Stecher, Bärbel ^a   Robbiani, Riccardo ^a   Walker, Alan W ^b   Westendorf, Astrid M ^c   Barthel, Manja ^a   Kremer, Marcus ^d   Chaffron, Samuel ^e   Macpherson, Andrew J ^f   Buer, Jan ^c   Parkhill, Julian ^b   Dougan, Gordon ^b   Von Mering, Christian ^e   Hardt, Wolf Dietrich ^a  

^a ETH ZURICH   (Switzerland)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM MUTANT; COLITIS; DISEASE MODEL; ENTERITIS; FEMALE; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SALMONELLA TYPHIMURIUM; SEROTYPE; UNINDEXED SEQUENCE; WILD TYPE;

ANIMALS; BACTERIA; COLITIS; FEMALE; GENOTYPE; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINES; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; RNA, RIBOSOMAL, 16S; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); MAMMALIA; MUS; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 35649026345     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.0050244     Document Type: Article

References (62)

1. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124: 837-848.
2. Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, et al. (2004) Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci U S A 101: 1981-1986.
3. Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, et al. (2005) Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307: 1955-1959.
4. Samuel BS, Gordon JI (2006) A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 103: 10011-10016.
5. Hooper LV, Gordon JI (2001) Commensal host-bacterial relationships in the gut. Science 292: 1115-1118.
6. Konrad A, Cong Y, Duck W, Borlaza R, Elson CO (2006) Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota. Gastroenterology 130: 2050-2059.
7. Hooper LV (2004) Bacterial contributions to mammalian gut development. Trends Microbiol 12: 129-134.
8. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect Immun 71: 2839-2858.
9. Bohnhoff M, Drake BL, Miller CP (1954) Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med 86: 132-137.
10. Hapfelmeier S, Hardt WD (2005) A mouse model for S. typhimurium-induced enterocolitis. Trends Microbiol 13: 497-503.
11. Coburn B, Li Y, Owen D, Vallance BA, Finlay BB (2005) Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect Immun 73: 3219-3227.
12. Stecher B, Paesold G, Barthel M, Kremer M, Jantsch J, et al. (2006) Chronic Salmonella enterica serovar Typhimurium-induced colitis and cholangitis in streptomycin-pretreated Nramp1+/+ mice. Infect Immun 74: 5047-5057.
13. Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M, et al. (2004) Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72: 795-809.
14. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
15. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102: 11070-11075.
16. Rawls JF, Mahowald MA, Ley RE, Gordon JI (2006) Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127: 423-433.
17. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
18. Lytle C, Tod TJ, Vo KT, Lee JW, Atkinson RD, et al. (2005) The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm Bowel Dis 11: 231-243.
19. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
20. Westendorf AM, Fleissner D, Deppenmeier S, Gruber AD, Bruder D, et al. (2006) Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 131: 510-524.
21. Dann SM, Eckmann L (2007) Innate immune defenses in the intestinal tract. Curr Opin Gastroenterol 23: 115-120.
22. Cash HL, Whitham CV, Behrendt CL, Hooper LV (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-1130.
23. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, et al. (2005) Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122: 461-472.
24. Navarre WW, Halsey TA, Walthers D, Frye J, McClelland M, et al. (2005) Coregulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol 56: 492-508.
25. Uzzau S, Bossi L, Figueroa-Bossi N (2002) Differential accumulation of Salmonella[Cu, Zn] superoxide dismutases SodCI and SodCII in intracellular bacteria: Correlation with their relative contribution to pathogenicity. Mol Microbiol 46: 147-156.
26. Bispham J, Tripathi BN, Watson PR, Wallis TS (2001) Salmonella pathogenicity island 2 influences both systemic salmonellosis and Salmonella-induced enteritis in calves. Infect Immun 69: 367-377.
27. Coombes BK, Coburn BA, Potter AA, Gomis S, Mirakhur K, et al. (2005) Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect Immun 73: 7161-7169.
28. Deng W, Vallance BA, Li Y, Puente JL, Finlay BB (2003) Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 48: 95-115.
29. Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, et al. (2006) Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infect Immun 74: 2522-2536.
30. Rabbani GH, Albert MJ, Rahman H, Islam M, Mahalanabis D, et al. (1995) Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Infect Immun 63: 4350-4357.
31. Sigel SP, Finkelstein RA, Parker CD (1981) Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel. Infect Immun 32: 474-479.
32. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
33. Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, et al. (2006) Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55: 1760-1767.
34. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43: 3380-3389.
35. Kressner MS, Williams SE, Biempica L, Das KM (1982) Salmonellosis complicating ulcerative colitis. Treatment with trimethoprim-sulfamethoxazole. JAMA 248: 584-585.
36. Hook EW (1961) Salmonellosis: Certain factors influencing the interaction of Salmonella and the human host. Bull N Y Acad Med 37: 499-512.
37. Taylor-Robinson S, Miles R, Whitehead A, Dickinson RJ (1989) Salmonella infection and ulcerative colitis. Lancet 1: 1145.
38. Lindeman RJ, Weinstein L, Levitan R, Patterson JF (1967) Ulcerative colitis and intestinal salmonellosis. Am J Med Sci 254: 855-861.
39. Isbister WH, Hubler M (1998) Inflammatory bowel disease in Saudi Arabia: Presentation and initial management. J Gastroenterol Hepatol 13: 1119-1124.
40. Szilagyi A, Gerson M, Mendelson J, Yusuf NA (1985) Salmonella infections complicating inflammatory bowel disease. J Clin Gastroenterol 7: 251-255.
41. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M (2002) Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 37: 1034-1041.
42. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, et al. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52: 237-242.
43. Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJ (2006) Differences between Crohn's disease and ulcerative colitis patients in tissue-associated intestinal microflora. J Clin Microbiol 44: 4136-4141.
44. Westendorf AM, Templin M, Geffers R, Deppenmeier S, Gruber AD, et al. (2005) CD4+ T cell mediated intestinal immunity: Chronic inflammation versus immune regulation. Gut 54: 60-69.
45. Morgan DJ, Liblau R, Scott B, Fleck S, McDevitt HO, et al. (1996) CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 157: 978-983.
46. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-239.
47. Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173: 697-703.
48. Cole JR, Chai B, Farris RJ, Wang Q, Kulam SA, et al. (2005) The Ribosomal Database Project (RDP-II): Sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res 33: D294-D296.
49. Hapfelmeier S, Stecher B, Barthel M, Kremer M, Müller A, et al. (2005) The Salmonella pathogenicity island (SPI)-1 and SPI-2 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 174: 1675-1685.
50. Stecher B, Hapfelmeier S, Muller C, Kremer M, Stallmach T, et al. (2004) Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72: 4138-4150.
51. Staden RJD, Bonfield JK (2003) Managing sequencing projects in the GAP4 environment. In: Krawetz SA, Womble DD, editors. Introduction to bioinformatics: A theoretical and practical approach. Totawa (New Jersey): Humana Press.
52. Ashelford KE, Chuzhanova NA, Fry JC, Jones AJ, Weightman AJ (2006) New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras. Appl Environ Microbiol 72: 5734-5741.
53. Edgar RC (2004) MUSCLE: A multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5: 113.
54. Ludwig W, Strunk O, Westram R, Richter L, Meier H, et al. (2004) ARB: A software environment for sequence data. Nucleic Acids Res 32: 1363-1371.
55. Huber T, Faulkner G, Hugenholtz P (2004) Bellerophon: A program to detect chimeric sequences in multiple sequence alignments. Bioinformatics 20: 2317-2319.
56. Ashelford KE, Chuzhanova NA, Fry JC, Jones AJ, Weightman AJ (2005) At least 1 in 20 16S rRNA sequence records currently held in public repositories is estimated to contain substantial anomalies. Appl Environ Microbiol 71: 7724-7736.
57. Ye J, McGinnis S, Madden TL (2006) BLAST: Improvements for better sequence analysis. Nucleic Acids Res 34: W6-W9.
58. Schloss PD, Handelsman J (2005) Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl Environ Microbiol 71: 1501-1506.
59. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, et al. (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56: 1919-1925.
60. Kusel K, Pinkart HC, Drake HL, Devereux R (1999) Acetogenic and sulfate-reducing bacteria inhabiting the rhizoplane and deep cortex cells of the sea grass Halodule wrightii. Appl Environ Microbiol 65: 5117-5123.
61. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142: 1097-1106.
62. Stecher B, Macpherson AJ, Hapfelmeier S, Kremer M, Stallmach T, et al. (2005) Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated with streptomycin. Infect Immun 73: 3228-3241.